Google's telegraphed buy of YouTube was finally announced yesterday afternoon. The search leader will pay some $1.65 Billion in GOOG shares to acquire the #1 video platform with over 100 million daily video viewings. Those CBS, Sony BMG, and Warner Music commitments will be worth a bit more now and should legitimize this business model.
More importantly, Google Inc. (NASDAQ: GOOG) may surpass Yahoo! Inc. (NASDAQ: YHOO) now as the number one combined destination on the web. Yahoo! and its properties still hold the pole position for overall web traffic on the web, with Google as number two, and MySpace coming in as number three. With the combined search from MySpace and with YouTube listed as number eight, Google might just take the lead. If not, it very well may eclipse it in the metric of stickiness and "time inside."
"The YouTube team has built an exciting and powerful media platform that complements Google's mission to organize the world's information and make it universally accessible and useful," said Eric Schmidt, Google's CEO.
Level 3 communications Inc. (NASDAQ: LVLT) is the newest YouTube bandwidth provider and it is trading up almost 1% this morning. Shares of Google are up 0.5% this morning, after closing up 2% at $429.00 yesterday.
Jon Ogg is a partner in 24/7 Wall St., LLC; he does not own securities in the companies he covers.
Last updated: February 09, 2012: 02:11 AM
Hot Stocks
DailyFinance Headlines
- The Money Man Behind Rick Santorum: Who Is Foster S. Friess?
- Twice the Heart, Half the Cost: Our Readers' Budget Valentine's Day Suggestions
- Is an Amazon Store in the Real World a Good Idea?
- What Are the Best Value Colleges? Princeton Review Guru Tells All
- Which Credit Card Rewards Does the IRS Care About?
Benzinga Headlines
- CVS Profit Up as Walgreen's Customers Defect
- Caesars IPO Inflates the Casino Bubble
- Americans Are Starting the Day at McDonalds
- Doomsday Capitalism: Just Getting Started or Going Out of Style?
- Sprint Reports Wider 4Q Loss
TheFlyOnTheWall.com Headlines
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- The Money Man Behind Rick Santorum: Who Is Foster S. Friess?
- Twice the Heart, Half the Cost: Our Readers' Budget Valentine's Day Suggestions
- Is an Amazon Store in the Real World a Good Idea?
- What Are the Best Value Colleges? Princeton Review Guru Tells All
- Which Credit Card Rewards Does the IRS Care About?
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
The Money Man Behind Rick Santorum: Who Is Foster S. Friess?
5 Signs You're Getting Robbed at the Hospital

